Gene · 57721
NIH grants1,078
NIH grants whose papers are about the gene, through NIH's grant-paper links.
801 to 820 of 1,078
Download this page as JSON| Grant | Title | METTL14 papers | Newest fiscal year |
|---|---|---|---|
| S10OD025120 | The 10x Chromium System for High-Throughput Single Cell Genomics | 1 | 2019 |
| T32GM007184 | Organization and Function of Cellular Structure | 1 | 2019 |
| T32GM007205 | Medical Scientist Training Program | 1 | 2019 |
| T32GM007309 | Medical Scientist Training Program | 1 | 2019 |
| T32GM007598 | Joint Program in Molecules,Cells and Organisms | 1 | 2019 |
| T32GM008715 | Biotechnology Training Grant | 1 | 2019 |
| T32GM008752 | Cellular and Molecular Medicine | 1 | 2019 |
| T32GM113770 | UC Davis Training Program in Chemical Biology | 1 | 2019 |
| U19MH107367 | Collaboration on preclinical autism cellular assays, biosignatures, and network analyses (Copacabana) | 1 | 2019 |
| U54HL127624 | Data Coordination and Integration Center for LINCS-BD2K | 1 | 2019 |
| R01GM071440 | Direct Oxidative Nucleic Acids Demethylation | 14 | 2018 |
| R56AI139234 | Epitranscriptomic regulation of HBV gene expression | 8 | 2018 |
| R01CA178454 | The role and functional mechanism of TET1 in MLL-rearranged leukemia | 6 | 2018 |
| R56DK120282 | The role, mechanism and therapeutic potential of TET1 in MDS | 6 | 2018 |
| R01CA182528 | Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia | 5 | 2018 |
| R21AI129851 | Mapping the RNA modification N6-methyladenosine during Zika virus infection | 4 | 2018 |
| F30GM120917 | Role of m6A in HNRNPG protein localization and HNRNPG-regulated alternative splicing | 3 | 2018 |
| P01CA177322 | Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses | 3 | 2018 |
| R00GM111430 | Elucidating the Inhibitory Mechanisms of RNA Triple Helices in Nuclear Decay | 3 | 2018 |
| R00MH104712 | mRNA Methylation: a Novel Regulatory Mechanism in the Neuronal Transcriptome | 3 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/grants?page=41